[Anthelmintic therapy of opisthorchiasis in patients with active tuberculosis].
Study was based on the clinical and laboratory follow up of 34 patients with active pulmonary tuberculosis in 12 of whom it was concurrent with opisthorchiasis. The clinical course of the combined pathology and immunopathogenesis were evaluated by the monocytic interleukin-1 capacity to regulate the immune T-system status. In conditions when the course of tuberculosis is aggravated by opisthorchiasis invasion, the number of cases of antibacterial therapy intolerance increases and prognosis of the diseases deteriorates, it is expedient to use the anthelminthic therapy with a new preparation biltricide which also has an immunomodulating action. It was shown that the antibacterial and anthelminthic therapy had a favourable clinical and immunologic effect.
Kashuba
E A
EA
Rusakova
L I
LI
D002648:Child; D006801:Humans; D007375:Interleukin-1 / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D009889:Opisthorchiasis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D011223:Praziquantel / Q000627:therapeutic use*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy* / Q000276:immunology
D007375:Interleukin-1; D011223:Praziquantel
Antigel'mintnaia terapiia opistorkhoza u bol'nykh s aktivnym tuberkulezom.